As children are often unable to accurately communicate and report their symptoms, researchers often rely on behavior as a proxy. Unlike clinical trials in adults which rely on. | April 19, 2023
Newport Beach-based VivoSense, a company using wearable sensors for the clinical trials market, says it has raised $25M in a Series A funding round. The roudn came from Debiopharm and the Perceptive Xont
Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers Funding round co-led by the Perceptive Xontogeny